Cargando…
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity Issues
In new drug development process, one of the most important milestones for a drug candidate is to establish Proof of Concept (PoC) at early Phase II stage. Among many challenges in PoC clinical trial design and analysis, the application of multiplicity comparison procedures (MCP) is frequently discus...
Autores principales: | Li, Qian H., Deng, Qiqi, Ting, Naitee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142878/ https://www.ncbi.nlm.nih.gov/pubmed/34028669 http://dx.doi.org/10.1007/s43441-021-00299-4 |
Ejemplares similares
-
Dose finding in drug development
por: Ting, Naitee
Publicado: (2006) -
Selected Thoughts on Hydrophobicity in Drug Design
por: Lou, Lillian L., et al.
Publicado: (2021) -
Proof of Concept (POC) Fund Selection (Selection and definition of grants for the project)
por: El Yacoubi, Sabrina
Publicado: (2017) -
A Morally Permissible Moral Mistake? Reinterpreting a Thought Experiment as Proof of Concept
por: Emmerich, Nathan, et al.
Publicado: (2018) -
Dynamic Region of Interest Selection in Remote Photoplethysmography: Proof-of-Concept Study
por: Kiddle, Adam, et al.
Publicado: (2023)